The global market size for Mycoplasma Testing was estimated at USD 609.39 million in 2019 and is projected to hit USD 1.59 billion by 2027, at a CAGR of 12.6 percent, according to the latest review of Reports and Data. Mycoplasma is the smallest recognised species of bacteria that has evolved from Gram-positive bacteria due to de-generative evolution. The bacterial mycoplasma cell has a missing cell wall and can be either saprotrophic or parasitic. While there are almost 200 distinct forms of mycoplasma bacteria, most of them are harmless. In humans, just 5 out of 200 cause serious infections.
In the human body, various mycoplasma species cause various diseases. Mycoplasma pneumonia, for instance, affects the throat and lungs, while urethra infection is linked to Mycoplasma genitalium. Mycoplasma testing is used in patients to investigate current or past infections with mycoplasma. Mycoplasma microbes in the genitourinary tract, throat, or respiratory tract of the patient may exist as healthy flora. In addition, mycoplasma bacterial cells are resistant to various traditional antibiotics due to the absence of cell walls. Testing for mycoplasma plays an important role in cell culture and this testing, including cell banks, viral seed stocks, and final products, is necessary for any phase of product growth.
Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/2129
The growth of the mycoplasma testing market is motivated by important research and development activities in the academic and bio-pharmaceutical industries, an increased occurrence of mycoplasma infections and contamination of cell culture. During cell culture, mycoplasma can spread easily through droplets and is hard to detect under a microscope. Therefore, to be identified, they require unique tests. Growing expenditure by leading market players in the healthcare sector to enhance consumer loyalty and achieve technological innovations is expected to stimulate the global mycoplasma testing market.
The demand for mycoplasma testing is also driven by increased acceptance of mycoplasma testing in the microbiology field, increased occurrence of water pollution-related infections, increased public and private sector investment in the healthcare industry, and greater understanding of mycoplasma bacterial infections. However, minimal awareness among patients and clinicians of mycoplasma infection and difficulties associated with its identification are expected to impede the growth of the market.
The demand for mycoplasma testing is increasing at a phenomenal 13 percent CAGR in Asia Pacific, followed by 12.8 percent and 12.5 percent CAGR in North America and Europe, respectively. Growing government funding, combined with high R&D investments, are key drivers of market growth in these regions.
Key participants in the mycoplasma testing market include:
- Thermo Fisher Scientific Inc.
- Lonza Group Ltd.
- Merck KGaA
- Roche Diagnostics
- American Type Culture Collection
- Bionique Testing Laboratories, Inc.
- InvivoGen
- PromoCell GmbH
- Norgen Biotek Corp.
- GenBio
- Meridian Bioscience, Inc.
- Savyon Diagnostics
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2129
Mycoplasma Testing Market: Segmentation
For the purpose of this report, Reports and Data has segmented the mycoplasma testing market on the basis of product type, technology type, application type, end use, and region:
Product Type (Revenue, USD Million; 2017–2027)
- Instruments
- Kits & Reagents
- PCR Assay
- Nucleic Acid Detection
- Elimination Kits & Reagent
- Stains
- Standards & Controls
- Others
- Services
- Others
Technology Type (Revenue, USD Million; 2017–2027)
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- DNA Staining
- Microbial Culture Techniques
- Enzymatic Methods
- Others
Application Type (Revenue, USD Million; 2017–2027)
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Others
End Use (Revenue, USD Million; 2017–2027)
- Pharmaceutical Companies
- Cell Banks
- Others
Regional Outlook (Revenue in USD Million; 2017–2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
To read more about the report, visit @ https://www.reportsanddata.com/report-detail/mycoplasma-testing-market
Thank you for reading our report. The customization of the report is available as per your research needs. Please get in touch with us, and our team will ensure you get the report tailored as per your requirements.
Similar Report:
1. Biochip Market Size, Trends & Analysis, By Product, By Application, By End-Use Vertical, By Region, Segment Forecasts To 2027
2. Consumer Genomics Market Size, Trends & Analysis, By Product, By Form and By Application, Forecasts To 202
No comments:
Post a Comment